Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/1/2022 | $31.00 | Neutral | Credit Suisse |
| 3/11/2022 | $29.00 → $31.00 | Neutral | Credit Suisse |
| 1/7/2022 | $25.00 → $29.00 | Underperform → Neutral | Credit Suisse |
| 11/9/2021 | $21.00 → $25.00 | Underperform | Credit Suisse |
Credit Suisse resumed coverage of Tivity Health with a rating of Neutral and set a new price target of $31.00
Credit Suisse reiterated coverage of Tivity Health with a rating of Neutral and set a new price target of $31.00 from $29.00 previously
Credit Suisse upgraded Tivity Health from Underperform to Neutral and set a new price target of $29.00 from $25.00 previously